Adit Ben-Baruch Selected Research

Chemokine CCL5

1/2020	Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy.
5/2015	Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.
9/2014	The chemokine system, and its CCR5 and CXCR4 receptors, as potential targets for personalized therapy in cancer.
8/2012	The Tumor-Promoting Flow of Cells Into, Within and Out of the Tumor Site: Regulation by the Inflammatory Axis of TNFα and Chemokines.
1/2012	Mechanisms regulating the secretion of the promalignancy chemokine CCL5 by breast tumor cells: CCL5's 40s loop and intracellular glycosaminoglycans.
4/2011	Inflammatory mediators in breast cancer: coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition.
10/2008	Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: a basis for tumor-promoting interactions.
8/2008	The inflammatory chemokines CCL2 and CCL5 in breast cancer.
8/2006	The chemokine CCL5 as a potential prognostic factor predicting disease progression in stage II breast cancer patients.
11/2002	Breast carcinoma: a report on the potential usage of the CC chemokine RANTES as a marker for a progressive disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Adit Ben-Baruch Research Topics

Disease

40	Neoplasms (Cancer) 05/2022 - 02/2002
29	Breast Neoplasms (Breast Cancer) 05/2022 - 02/2002
16	Neoplasm Metastasis (Metastasis) 01/2020 - 02/2002
7	Inflammation (Inflammations) 01/2020 - 08/2007
5	Triple Negative Breast Neoplasms 02/2022 - 01/2019
4	Disease Progression 01/2020 - 02/2002
3	Neuroblastoma 01/2009 - 03/2004
3	Adenocarcinoma 03/2004 - 02/2002
2	Lymphatic Metastasis 01/2016 - 01/2008
1	Bone Resorption 01/2020
1	Cardiomyopathies (Cardiomyopathy) 01/2017
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2014
1	Inborn Genetic Diseases (Disease, Hereditary) 05/2010
1	Job Syndrome (Hyper-IgE Syndrome) 05/2010
1	Bacterial Infections (Bacterial Infection) 05/2010
1	Pleural Effusion (Pleural Effusions) 10/2008
1	Noninfiltrating Intraductal Carcinoma (DCIS) 10/2008
1	Ductal Carcinoma 10/2008
1	Melanoma (Melanoma, Malignant) 01/2008

Drug/Important Bio-Agent (IBA)

23	ChemokinesIBA 05/2022 - 03/2004
13	CytokinesIBA 03/2021 - 02/2002
12	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 02/2002
11	Chemokine CCL5IBA 01/2020 - 02/2002
8	Phenobarbital (Luminal)FDA Link 02/2022 - 01/2013
6	Estrogens (Estrogen)FDA Link 02/2020 - 01/2005
6	Epidermal Growth Factor (EGF)IBA 02/2020 - 01/2005
5	Chemokine ReceptorsIBA 03/2021 - 03/2004
4	Interleukin-6 (Interleukin 6)IBA 01/2020 - 10/2003
4	LigandsIBA 01/2009 - 03/2004
3	InterleukinsIBA 03/2021 - 05/2015
3	Matrix Metalloproteinases (MMPs)IBA 01/2020 - 10/2003
3	CXCR4 Receptors (CXCR4 Receptor)IBA 01/2020 - 03/2004
3	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 09/2014 - 08/2008
3	Chemotactic FactorsIBA 05/2010 - 02/2002
3	CC ChemokinesIBA 01/2005 - 02/2002
2	AntibodiesIBA 02/2022 - 02/2005
2	Interleukin-8 (Interleukin 8)IBA 01/2020 - 03/2011
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 01/2012
2	Conditioned Culture MediaIBA 07/2017 - 05/2015
2	GlycosaminoglycansIBA 09/2014 - 01/2012
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 03/2014 - 01/2012
2	Estrogen ReceptorsIBA 03/2011 - 08/2006
2	Proteins (Proteins, Gene)FDA Link 10/2009 - 03/2004
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2007 - 01/2005
2	Chemokine CXCL12IBA 02/2005 - 03/2004
1	Type II Tumor Necrosis Factor ReceptorsIBA 01/2021
1	Notch ReceptorsIBA 01/2019
1	InflammasomesIBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Small Interfering RNA (siRNA)IBA 01/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2016
1	RNA (Ribonucleic Acid)IBA 01/2016
1	HydrogelsIBA 01/2016
1	LuciferasesIBA 03/2014
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 03/2014
1	Maraviroc FDA Link 01/2014
1	plerixafor FDA Link 01/2014
1	PaxillinIBA 01/2013
1	ElementsIBA 01/2013
1	NF-kappa B (NF-kB)IBA 01/2012
1	ErbB Receptors (EGF Receptor)IBA 03/2011
1	Complement System Proteins (Complement)IBA 03/2011
1	Immunoglobulin E (IgE)IBA 05/2010
1	GTP Phosphohydrolases (GTPases)IBA 10/2009
1	Focal Adhesion Protein-Tyrosine KinasesIBA 10/2009
1	CX3C Chemokine Receptor 1IBA 01/2009
1	Hormones (Hormone)IBA 01/2009
1	Biomarkers (Surrogate Marker)IBA 08/2006
1	Progesterone Receptors (Progesterone Receptor)IBA 08/2006
1	CXC ChemokinesIBA 02/2005
1	Progesterone FDA LinkGeneric 01/2005
1	Vascular Endothelial Growth FactorsIBA 01/2005
1	Peptide Hydrolases (Proteases)FDA Link 02/2002

Therapy/Procedure

8	Therapeutics 02/2022 - 03/2011
4	Drug Therapy (Chemotherapy) 01/2021 - 01/2013
2	Immunotherapy 01/2021 - 07/2020
1	Injections 12/2016
1	Transplantation 01/2014
1	Hematopoietic Stem Cell Mobilization 01/2014